SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.205   0.0044 (+2.19%) Volume: 514.57k 11:04 AM EDT Mar 31, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities104/18/2016
4Statement of changes in beneficial ownership of securities104/18/2016
10-KAnnual report pursuant to Section 13 or 15(d)11903/11/2016
8-KCurrent report pursuant to Section 13 or 15(d)2812/24/2015
SC 13D/A[Amend] General statement of acquisition of beneficial ownership212/23/2015
8-KCurrent report pursuant to Section 13 or 15(d)412/16/2015
DEFA14AAdditional proxy soliciting materials - definitive211/27/2015
8-KCurrent report pursuant to Section 13 or 15(d)811/27/2015
8-KCurrent report pursuant to Section 13 or 15(d)511/18/2015
DEF 14AOther definitive proxy statements18111/12/2015
10-QGeneral form for quarterly reports under Section 13 or 15(d)5110/30/2015
10-QGeneral form for quarterly reports under Section 13 or 15(d)10008/07/2015
8-KCurrent report pursuant to Section 13 or 15(d)708/03/2015
424B5Prospectus [Rule 424(b)(5)]7506/05/2015
8-KCurrent report pursuant to Section 13 or 15(d)5206/05/2015
5678910111213141516171819